14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

Links shared publicly online about this topic.

793
total visits

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.

View full resource at news-medical.net

Tags: Bone, Osteoporosis, Osteoporosis Medication, Drug, Evista, Forteo, Eli Lilly and Company